Narayana Hrudayalaya logo

Narayana Hrudayalaya CEO, MD, chairman, board of directors and AGM

NSE: NHBSE: 539551Healthcare ServicesMid Cap

Last close ₹1,646.90down ₹46.30 (2.73%)BSE ₹1,647.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,693.20.

52-week range of traded prices to 23 Oct 2026
₹1,589.00Low, 2 Apr 2026₹2,093.30High, 17 Nov 2025
Market cap
₹33,656 Cr235th largest listed
P/E
41.2
P/B
7.4
Dividend yield
0.27%
ROE
20.0%
ROCE
13.1%
Debt to equity
1.07
Volume, NSE
1,97,68749.1% delivered

Narayana Hrudayalaya board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonDevi Prasad Shetty
  • Managing director and CEOEmmanuel Rupert
  • Company Secretary and Compliance OfficerSridhar S.

10 directors5 independent3 executive2 non-executive

  • Devi Prasad Shetty · ChairpersonExecutive · joined Jul 2000 · reappointed Aug 2023 · 1 listed board
  • Emmanuel Rupert · Managing director and CEOExecutive · joined Feb 2019 · reappointed Feb 2025 · 1 listed board · 2 committee seats
  • Viren Prasad ShettyExecutive · joined Apr 2008 · reappointed Aug 2024 · 1 listed board · 2 committee seats
  • Kiran Mazumdar ShawNon-executive · joined Feb 2008 · reappointed Aug 2026 · 4 listed boards · 1 as independent
  • Terri Smith BresenhamIndependent · joined Aug 2021 · reappointed Aug 2026 · 61 months as independent · 1 listed board · 1 as independent
  • Shankar ArunachalamIndependent · joined Feb 2023 · reappointed Feb 2023 · 43 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
  • Nachiket Madhusudan MorIndependent · joined Feb 2023 · reappointed Feb 2023 · 43 months as independent · 2 listed boards · 2 as independent · 7 committee seats, 2 as chair
  • Naveen TewariIndependent · joined Mar 2023 · reappointed Mar 2023 · 42 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair
  • Anesh ShettyNon-executive · joined Jun 2024 · reappointed Jun 2024 · 1 listed board
  • Nivruti RaiIndependent · joined Jun 2024 · reappointed Jun 2024 · 27 months as independent · 2 listed boards · 2 as independent · 2 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 31 Jul 20269 of 10 present5 independent · 69 days in between
    • 22 May 20269 of 10 present5 independent

  • Audit Committee

    Chair Shankar Arunachalam

    Nachiket Madhusudan Mor, Emmanuel Rupert, Nivruti Rai

    • 31 Jul 20263 of 4 present2 independent · 69 days in between
    • 22 May 20263 of 3 present3 independent

  • Nomination and remuneration committee

    Chair Terri Smith Bresenham

    Kiran Mazumdar Shaw, Naveen Tewari

    • 19 May 20262 of 3 present2 independent

  • Stakeholders Relationship Committee

    Chair Naveen Tewari

    Viren Prasad Shetty, Nachiket Madhusudan Mor

    • 20 May 20263 of 3 present2 independent · no day in between

  • Risk Management Committee

    Chair Shankar Arunachalam

    Nachiket Madhusudan Mor, Emmanuel Rupert, Nivruti Rai

    • 31 Jul 20263 of 4 present2 independent · 69 days in between
    • 22 May 20263 of 3 present3 independent

  • Corporate Social Responsibility Committee

    Chair Nachiket Madhusudan Mor

    Viren Prasad Shetty, Terri Smith Bresenham

    • 20 May 20263 of 3 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • M/s. Deloitte Haskins & Sells LLPPeer-review certificate valid to Jul 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Narayana Hrudayalaya AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Narayana Hrudayalaya dividend history

Postal ballot, 4 Oct 2026

2,11,999 shareholders on the register on 28 Aug 2026; votes counted by Sudhindra K S / Sudhindra K S.The company's voting result (opens in a new tab)

  1. To approve revision in professional fee payable to Dr. Varun Shetty as a Consultant Surgeon, an office or place of profit under the Companies Act, 2013.
    OrdinaryPromoters have an interest in it
    91.02% for8.98% against

    Against: promoters 0.00% · institutions 43.37% · other public 0.33%

    Turnout: all 77.11% · promoters 92.10% · institutions 81.80% · other public 16.78%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 14 Aug 2026, 11 resolutions

2,13,194 shareholders on the register on 7 Aug 2026; present: 6 promoters and 55 others; votes counted by Sudhindra K S / Sudhindra K S.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and the Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.86% · other public 16.47%

  2. To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2026, together with the report of the Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.86% · other public 16.47%

  3. To declare dividend of Rs 4.50 per Equity Share for the financial year ended March 31, 2026
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.64% · promoters 100.00% · institutions 80.88% · other public 16.47%

  4. To appoint a Director in place of Dr. Kiran Mazumdar Shaw (DIN: 00347229), who retires by rotation and being eligible, offers herself for re-appointment.
    Ordinary
    94.73% for5.27% against

    Against: promoters 0.00% · institutions 27.82% · other public 0.01%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.87% · other public 16.47%

  5. To ratify the remuneration payable to the Cost Auditors for the Financial Year 2026-27
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.87% · other public 16.44%

  6. To approve reappointment of Ms. Terri Smith Bresenham (DIN: 09111500) as an Independent Director of the Company for the second term of five consecutive years effective from August 5, 2026
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.14% · other public 0.01%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.87% · other public 16.47%

  7. To approve revision in remuneration of Dr. Devi Prasad Shetty (DIN: 00252187) as Whole-time Director of the Company
    SpecialPromoters have an interest in it
    99.50% for0.51% against

    Against: promoters 0.00% · institutions 2.67% · other public 0.01%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.87% · other public 16.47%

  8. To approve revision in remuneration of Mr. Viren Prasad Shetty (DIN:02144586) as Whole-time Director, designated as Executive Vice Chairman of the Company
    SpecialPromoters have an interest in it
    99.79% for0.21% against

    Against: promoters 0.00% · institutions 1.09% · other public 0.02%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.87% · other public 16.47%

  9. To approve revision in remuneration of Dr. Emmanuel Rupert (DIN: 07010883), as Managing Director and Group CEO of the Company
    Special
    99.68% for0.32% against

    Against: promoters 0.00% · institutions 1.69% · other public 0.02%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.87% · other public 16.47%

  10. To approve payment of Remuneration to Non-executive Directors
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.87% · other public 16.47%

  11. To approve issue of Debt Securities on Private Placement Basis
    Special
    99.77% for0.23% against

    Against: promoters 0.00% · institutions 1.21% · other public 0.01%

    Turnout: all 81.63% · promoters 100.00% · institutions 80.87% · other public 16.47%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Meeting called by the tribunal, 2 Apr 2026, 1 resolution

2,25,776 shareholders on the register on 26 Mar 2026; present: 4 promoters and 39 others; votes counted by Ms. Manali Shah / Not applicable.The company's voting result (opens in a new tab)

  1. Approval of Scheme of Arrangement between NH Integrated Care Private Limited (Demerged Company) and Narayana Hrudayalaya Limited (Resulting Company) and their respective shareholders & creditors pursuant to Sections 230–232 of the Companies Act, 2013, as directed by the National Company Law Tribunal, Bengaluru Bench.MoreLess
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 79.25% · promoters 100.00% · institutions 79.96% · other public 3.30%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Meeting called by the tribunal, 19 Jan 2026, 1 resolution

2,26,681 shareholders on the register on 12 Jan 2026; present: 6 promoters and 29 others; votes counted by Sachin Kumar Jhankal / Sachin Jhankal and Associates.The company's voting result (opens in a new tab)

  1. Approval of Scheme of Arrangement of Meridian Medical Research & Hospital Ltd (Transferor Company) and Narayana Hrudayalaya Limited (Transferee Company) and their respective shareholders & creditors pursuant to Sections 230–232 of the Companies Act, 2013, as directed by the National Company Law Tribunal, Bengaluru Bench.MoreLess
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 79.43% · promoters 100.00% · institutions 71.81% · other public 3.22%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Aug 2025, 13 resolutions

2,31,054 shareholders on the register on 22 Aug 2025; present: 6 promoters and 60 others; votes counted by Sudhindra K S / Sudhindra K S.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2025, together with the reports of the Board of Directors and the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.02% · other public 0.00%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  2. To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2025, together with the report of the Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.02% · other public 0.00%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  3. To declare dividend of Rs. 4.50 per Equity Share for the financial year ended March 31, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  4. To appoint a Director in place of Dr. Devi Prasad Shetty (DIN: 00252187), who retires by rotation and being eligible, offers himself for re-appointment.
    OrdinaryPromoters have an interest in it
    99.51% for0.49% against

    Against: promoters 0.00% · institutions 2.67% · other public 0.05%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  5. To appoint M/s. Vinod Kothari & Company, Practicing Company Secretaries, Kolkata as Secretarial Auditors of the Company.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.90% · other public 3.56%

  6. To ratify the remuneration payable to the Cost Auditors for the Financial Year 2025-26.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  7. To approve revision in remuneration of Dr. Devi Prasad Shetty (DIN: 00252187) as Whole-time Director of the Company
    SpecialPromoters have an interest in it
    98.68% for1.32% against

    Against: promoters 0.00% · institutions 7.13% · other public 0.06%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  8. To approve revision in remuneration of Mr. Viren Prasad Shetty (DIN:02144586) as Whole-time Director, designated as Executive Vice Chairman of the Company.
    SpecialPromoters have an interest in it
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.16% · other public 0.07%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  9. To approve revision in remuneration of Dr. Emmanuel Rupert (DIN: 07010883), as Managing Director and Group CEO of the Company
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.16% · other public 0.06%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  10. To approve issue of Debt Securities on Private Placement Basis
    Special
    99.76% for0.24% against

    Against: promoters 0.00% · institutions 1.32% · other public 0.05%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  11. Increase in borrowing powers of Board of Directors under Section 180(1)(c) of the Companies Act, 2013
    Special
    99.76% for0.24% against

    Against: promoters 0.00% · institutions 1.32% · other public 0.03%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  12. Increase in provision for security in connection with the borrowings not exceeding Rs. 5,000 Crores under Section 180(1)(a) of the Companies Act, 2013
    Special
    99.76% for0.24% against

    Against: promoters 0.00% · institutions 1.32% · other public 0.03%

    Turnout: all 79.11% · promoters 100.00% · institutions 79.91% · other public 3.56%

  13. To approve increase in the limits for providing loans, Guarantee, Security and making Investments under Section 186 of the Companies Act, 2013.
    Special
    88.29% for11.71% against

    Against: promoters 0.00% · institutions 63.91% · other public 0.07%

    Turnout: all 78.95% · promoters 100.00% · institutions 79.05% · other public 3.56%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 11 Jan 2025, 1 resolution

1,83,348 shareholders on the register on 6 Dec 2024; votes counted by Sudhindra K S / Sudhindra K S.The company's voting result (opens in a new tab)

  1. To Re-appoint Dr. Emmanuel Rupert (DIN: 07010883) as Managing Director and Group Chief Executive Officer of the Company for a period of three years effective February 11, 2025 to February 10, 2028
    Special
    99.01% for0.99% against

    Against: promoters 0.00% · institutions 5.53% · other public 0.09%

    Turnout: all 78.49% · promoters 100.00% · institutions 78.24% · other public 3.21%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Aug 2024, 15 resolutions

Present: 7 promoters and 71 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the audited nstandalone financial statements of the Company for nthe financial year ended March 31, 2024, together nwith the reports of the Board of Directors and the nAuditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  2. To receive, consider and adopt the audited nconsolidated financial statements of the Company nfor the financial year ended March 31, 2024, together nwith the report of the Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  3. To declare dividend of Rs. 4.00 per Equity Share for nthe financial year ended March 31, 2024
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.14% · promoters 100.00% · institutions 73.51% · other public 22.43%

  4. To appoint a Director in place of Mr. Viren Prasad nShetty (DIN: 02144586), who retires by rotation and nbeing eligible, offers himself for re-appointment.
    OrdinaryPromoters have an interest in it
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 0.67% · other public 0.01%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  5. To ratify the remuneration payable to the Cost nAuditors for the Financial Year 2024-25
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  6. To appoint Ms. Nivruti Rai (DIN: 01353079) as an nIndependent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.02% · other public 0.00%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  7. To appoint Dr. Anesh Shetty (DIN: 06923555) as a nNon-Executive Non-Independent Director of the nCompany.
    OrdinaryPromoters have an interest in it
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 0.67% · other public 0.01%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  8. To approve revision in remuneration of Dr. Devi nPrasad Shetty (DIN: 00252187) as Whole-time nDirector of the Company
    SpecialPromoters have an interest in it
    98.62% for1.38% against

    Against: promoters 0.00% · institutions 8.48% · other public 0.01%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  9. To approve revision in remuneration of Mr. Viren nPrasad Shetty (DIN:02144586) as Whole-time nDirector, designated as Executive Vice Chairman of nthe Company
    SpecialPromoters have an interest in it
    98.66% for1.34% against

    Against: promoters 0.00% · institutions 8.20% · other public 0.02%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  10. To approve revision in remuneration of Dr. Emmanuel nRupert (DIN: 07010883), as Managing Director and nGroup CEO of the Company
    Special
    98.66% for1.34% against

    Against: promoters 0.00% · institutions 8.20% · other public 0.02%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  11. To approve revision in professional fee payable to nDr. Varun Shetty as a Consultant Surgeon, an office nor place of profit under the Companies Act, 2013.
    OrdinaryPromoters have an interest in it
    91.19% for8.81% against

    Against: promoters 0.00% · institutions 50.87% · other public 0.02%

    Turnout: all 76.11% · promoters 92.17% · institutions 73.35% · other public 22.43%

  12. To approve the professional fee payable to Dr. Vivek nShetty as a Consultant Surgeon, an office or place nof profit under the Companies Act, 2013.
    OrdinaryPromoters have an interest in it
    96.09% for3.91% against

    Against: promoters 0.00% · institutions 24.02% · other public 0.02%

    Turnout: all 81.11% · promoters 100.00% · institutions 73.35% · other public 22.43%

  13. To approve issue of Debt Securities on Private nPlacement Basis
    Special
    99.81% for0.19% against

    Against: promoters 0.00% · institutions 1.18% · other public 0.01%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  14. Increase in borrowing powers of Board of Directors nunder Section 180(1)(c) of the Companies Act, 2013
    Special
    99.81% for0.19% against

    Against: promoters 0.00% · institutions 1.18% · other public 0.02%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

  15. Increase in provision for security in connection nwith the borrowings not exceeding Rs.3,000 Crores nunder Section 180(1)(a) of the Companies Act, 2013
    Special
    99.81% for0.19% against

    Against: promoters 0.00% · institutions 1.18% · other public 0.04%

    Turnout: all 81.13% · promoters 100.00% · institutions 73.45% · other public 22.43%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 4 Aug 2023, 10 resolutions

Present: 6 promoters and 58 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the audited financial statements of the Company including the audited consolidated financial statements for the financial year ended 31st March 2023, together with the reports of the Board of Directors and the Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 82.41% · promoters 100.00% · institutions 77.73% · other public 4.48%

  2. To declare dividend of Rs. 2.50 per Equity Share for the financial year ended 31st March 2023
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 82.45% · promoters 100.00% · institutions 77.90% · other public 4.48%

  3. To appoint a director in place of Dr. Kiran Mazumdar Shaw (DIN: 00347229), who retires by rotation and being eligible, offers herself for re-appointment
    Ordinary
    99.32% for0.68% against

    Against: promoters 0.00% · institutions 3.11% · other public 0.03%

    Turnout: all 82.43% · promoters 100.00% · institutions 77.79% · other public 4.48%

  4. To ratify remuneration payable to the Cost Auditors for the Financial Year 2023-24
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 82.43% · promoters 100.00% · institutions 77.79% · other public 4.48%

  5. To approve revision in remuneration of Dr. Devi Prasad Shetty (DIN: 00252187) as Whole- time Director of the Company till the end of his current tenure, i.e. upto 28th August 2023
    SpecialPromoters have an interest in it
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.31% · other public 0.03%

    Turnout: all 82.43% · promoters 100.00% · institutions 77.79% · other public 4.48%

  6. To approve revision in remuneration of Mr. Viren Prasad Shetty (DIN:02144586) as Whole-time Director, designated as Executive Vice Chairman of the Company till the end of his current tenure, i.e. upto 28th August 2023MoreLess
    SpecialPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.05% · other public 0.05%

    Turnout: all 82.43% · promoters 100.00% · institutions 77.79% · other public 4.48%

  7. To approve revision in remuneration of Dr. Emmanuel Rupert (DIN: 07010883), as Managing Director and Group CEO of the Company
    Special
    99.51% for0.49% against

    Against: promoters 0.00% · institutions 2.26% · other public 0.07%

    Turnout: all 82.43% · promoters 100.00% · institutions 77.79% · other public 4.48%

  8. To approve re-appointment of Dr. Devi Prasad Shetty (DIN:00252187) as Whole-time Director of the Company for a term of five years effective from 29th August 2023
    SpecialPromoters have an interest in it
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.32% · other public 0.02%

    Turnout: all 82.43% · promoters 100.00% · institutions 77.79% · other public 4.48%

  9. To approve re-appointment of Mr. Viren Prasad Shetty (DIN:02144586), as Whole-time Director (designated as Executive Vice Chairman) of the Company for a term of five years effective from 29th August 2023MoreLess
    SpecialPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.06% · other public 0.04%

    Turnout: all 82.43% · promoters 100.00% · institutions 77.79% · other public 4.48%

  10. To approve issue of Debt Securities on Private Placement Basis
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 82.43% · promoters 100.00% · institutions 77.79% · other public 4.48%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 14 Aug 2026, 9 fund houses so far (houses' deadline to file 15 Oct 2026)

  • To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and the Auditors thereonMoreLess
    9 for0 against
  • To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2026, together with the report of the Auditors thereon
    9 for0 against
  • To declare dividend of Rs 4.50 per Equity Share for the financial year ended March 31, 2026
    9 for0 against
  • To appoint a Director in place of Dr. Kiran Mazumdar Shaw (DIN: 00347229), who retires by rotation and being eligible, offers herself for re-appointment.
    9 for0 against
  • To ratify the remuneration payable to the Cost Auditors for the Financial Year 2026-27
    9 for0 against
  • To approve reappointment of Ms. Terri Smith Bresenham (DIN: 09111500) as an Independent Director of the Company for the second term of five consecutive years effective from August 5, 2026
    9 for0 against
  • To approve revision in remuneration of Dr. Devi Prasad Shetty (DIN: 00252187) as Whole-time Director of the Company
    9 for0 against
  • To approve revision in remuneration of Mr. Viren Prasad Shetty (DIN:02144586) as Whole-time Director, designated as Executive Vice Chairman of the Company
    9 for0 against
  • To approve revision in remuneration of Dr. Emmanuel Rupert (DIN: 07010883), as Managing Director and Group CEO of the Company
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundGovernance and Transparency Concern: Director holding 3 full-time Position along with Group CEO.
    • Edelweiss Mutual Fund, Navi Mutual FundNo concerns on the merits of the proposed appointee or the remuneration proposed. Governance and Transparency Concern: Director holding 3 full-time Position along with Group CEO.
    6 for3 against
  • To approve payment of Remuneration to Non-executive Directors
    9 for0 against
  • To approve issue of Debt Securities on Private Placement Basis
    9 for0 against

Mutual fund votes, meeting of 2 Apr 2026, 26 fund houses

  • Approval of Scheme of Arrangement between NH Integrated Care Private Limited (Demerged Company) and Narayana Hrudayalaya Limited (Resulting Company) and their respective shareholders & creditors pursuant to Sections 230–232 of the Companies Act, 2013, as directed by the National Company Law Tribunal, Bengaluru Bench.MoreLess
    26 for0 against
5 earlier meetings

Mutual fund votes, meeting of 19 Jan 2026, 29 fund houses

  • Approval of Scheme of Arrangement of Meridian Medical Research & Hospital Ltd (Transferor Company) and Narayana Hrudayalaya Limited (Transferee Company) and their respective shareholders & creditors pursuant to Sections 230–232 of the Companies Act, 2013, as directed by the National Company Law Tribunal, Bengaluru Bench.MoreLess
    29 for0 against

Mutual fund votes, meeting of 29 Aug 2025, 23 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2025, together with the reports of the Board of Directors and the Auditors thereon.MoreLess
    23 for0 against
  • To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2025, together with the report of the Auditors thereon.
    22 for0 against
  • To declare dividend of Rs. 4.50 per Equity Share for the financial year ended March 31, 2025.
    22 for0 against
  • To appoint a Director in place of Dr. Devi Prasad Shetty (DIN: 00252187), who retires by rotation and being eligible, offers himself for re-appointment.
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundGovernance concern: Holding combined position of Chairman and Executive Director.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with law. No concerns on the merits of the proposed appointee or the remuneration proposed. Governance concern: Holding combined position of Chairman and Executive Director
    17 for6 against
  • To appoint M/s. Vinod Kothari & Company, Practicing Company Secretaries, Kolkata as Secretarial Auditors of the Company.
    22 for0 against
  • To ratify the remuneration payable to the Cost Auditors for the Financial Year 2025-26.
    22 for0 against
  • To approve revision in remuneration of Dr. Devi Prasad Shetty (DIN: 00252187) as Whole-time Director of the Company
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundGovernance concern: Holding combined position of Chairman and Executive Director.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with law. No concerns on the merits of the proposed appointee or the remuneration proposed. Governance concern: Holding combined position of Chairman and Executive Director.
    16 for6 against
  • To approve revision in remuneration of Mr. Viren Prasad Shetty (DIN:02144586) as Whole-time Director, designated as Executive Vice Chairman of the Company.
    22 for0 against
  • To approve revision in remuneration of Dr. Emmanuel Rupert (DIN: 07010883), as Managing Director and Group CEO of the Company
    23 for0 against
  • To approve issue of Debt Securities on Private Placement Basis
    22 for0 against
  • Increase in provision for security in connection with the borrowings not exceeding Rs. 5,000 Crores under Section 180(1)(a) of the Companies Act, 2013
    15 for0 against
  • To approve increase in the limits for providing loans, Guarantee, Security and making Investments under Section 186 of the Companies Act, 2013.
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, Mirae Asset Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PPFAS Mutual Fund, Sundaram Mutual Fund, Taurus Mutual Fund, UTI Mutual Fund
    • Angel One Mutual FundGovernance & Transparency Concern: Omnibus approval with Inadequate disclosures with respect to specific plan for utilization of said limit, the recipient of the proposed loans/ investments, etc.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Navi Mutual FundCompliant with the law. Governance & Transparency Concern: Omnibus approval with Inadequate disclosures w.r.t specific plan for utilization of said limit, the recipient of the proposed loans/ investments, etc.
    • HDFC Mutual FundThe company must disclose granular details including names of these companies, the nature and size of their operations and terms of support, to enable shareholders to make an informed decision. Given the lack of clarity, we do not support the resolution.
    • ICICI Prudential Mutual FundOn 31 March 2025, the aggregate value of investments, loans advanced, guarantees given and security provided outstanding were well within the existing limit of Rs. 35.0 bn. Hence the need for an increase in limit to Rs. 50.0 bn is unclear. Also, while support extended previously has been primarily to subsidiaries, it is unclear if future support will only be restricted to subsidiary companies. Due to lack of details regarding the extension of loans or guarantees and the counterparties involved, the AMC has voted against the resolution.
    • Mirae Asset Mutual FundWhile resolution is within companies act, disclosures are inadequate
    • Nippon India Mutual FundGovernance & Transparency Concern: Omnibus approval and Inadequate disclosures w.r.t specific plan for utilization of said limit, the recipient of the proposed loans/ investments, etc.
    • PPFAS Mutual FundThough compliant with the law, there are other concerns with regard to inadequate disclosures. Company should seek approval for specific investments instead of an all-inclusive approval. It lacks adequate disclosure with regards to proposed recipient for the loan / guarantee/ making investments, also lacks adequate disclosure as to how it proposes to utilize the said limits and what would be the terms and conditions of the proposed facilities.
    • Sundaram Mutual Fund, Taurus Mutual FundOn 31 March 2025, the aggregate value of investments, loans advanced, guarantees given and security provided outstanding were Rs. 8.8 bn. Considering, the adequate headroom available under the existing limit of Rs. 35.0 bn, which is high, the need for an increase in limit to Rs. 50.0 bn is unclear. Also, while support extended previously has been primarily to subsidiaries, it is unclear if future support will only be restricted to subsidiary companies. Due to lack of granular details regarding the extension of loans or guarantees and the counterparties involved, we are unable to provide an informed view. The company must disclose granular details including names of these companies, the nature and size of their operations and terms of support, to enable shareholders to make an informed decision. Given the lack of clarity, we do not support the resolution.
    • UTI Mutual FundGiven the lack of clarity, we do not support the resolution.
    6 for13 against
17 proposals not matched to one resolution
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against
  • Item 8, as a fund house numbered it
    1 for0 against
  • Item 10, as a fund house numbered it
    1 for0 against
  • Item 11, as a fund house numbered it
    1 for0 against
  • Item 12, as a fund house numbered it
    1 for0 against
  • 11) Approve increase in borrowing limits to Rs.50.0 bn from Rs. 30.0 bn.
    1 for0 against
  • 12) Approve increase in limit for creation of charge on the assets to Rs. 50.0 bn from Rs. 30.0 bn.
    1 for0 against
  • Approve increase in borrowing limits to Rs.50.0 bn from Rs. 30.0 bn
    5 for0 against
  • Approve increase in limit for creation of charge on the assets to Rs. 50.0 bn from Rs. 30.0 bn
    5 for0 against
  • Approve increase in limit for loans, guarantees and investments under Section 186 of Companies Act 2013 from Rs. 35.0 bn to Rs. 50.0 bn
    Against Jio BlackRock Mutual Fund, Unifi Mutual Fund
    • Jio BlackRock Mutual Fund, Unifi Mutual FundOn 31 March 2025, the aggregate value of investments, loans advanced, guarantees given and security provided outstanding were Rs. 8.8 bn. Considering, the adequate headroom available under the existing limit of Rs. 35.0 bn, which is high, the need for an increase in limit to Rs. 50.0 bn is unclear. Also, while support extended previously has been primarily to subsidiaries, it is unclear if future support will only be restricted to subsidiary companies. Due to lack of granular details regarding the extension of loans or guarantees and the counterparties involved, we are unable to provide an informed view. The company must disclose granular details including names of these companies, the nature and size of their operations and terms of support, to enable shareholders to make an informed decision. Given the lack of clarity, we do not support the resolution.
    1 for2 against
  • To borrow any sum or sums of moneys from time to time, for the purpose of business of the Company in rupee currency and / or foreign currency from, including but not limited to, any one or more banks, financial institutions, persons, firms, companies and bodies corporates, notwithstanding that the money or moneys to be borrowed, together with the moneys already borrowed by the Company (apart from temporary loans obtained from the Company’s Bankers in the ordinary course of business), may exceed aggregate of its paid-up share capital and free reserves, provided however, the total amount so borrowed shall not exceed Rs 5,000 crores and the Board is authorised to arrange or fix the terms and conditions of all such monies to be borrowed from time to time as to interest, repayment, security or otherwise as it may, in its absolute discretion, think fit.MoreLess
    16 for0 against
  • To give loan(s) and/ or give guarantee(s) and/or provide any security(ies) in connection with the loan(s) made to any person(s), any other body corporate(s) whether Indian or overseas including subsidiaries and associate companies of the Company, and to make investments and acquire by way of subscription, purchase or otherwise, the securities of any nature including equity shares and debentures or other debt securities of any other body corporate(s) or person(s) whether Indian or overseas including subsidiaries and associate companies of the Company and invest in schemes/units of mutual funds or such other funds and any other securities and instruments as may be required from time to time as the Board of Directors may in their absolute discretion deem beneficial and in the interest of the Company, exceeding sixty percent of the Paid up Share Capital, Free Reserves and Securities Premium Account or One Hundred Percent of the Free Reserves and Securities Premium Account of the Company, whichever is more, provided that the total of the investments made, loans, guarantees given and securities provided shall not at any time exceed Rs. 5,000 Crores.MoreLess
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with the law. Governance & Transparency Concern: Omnibus approval with Inadequate disclosures w.r.t specific plan for utilization of said limit, the recipient of the proposed loans/ investments, etc.
    0 for1 against
  • To pledge, mortgage, hypothecate, and/or to create charge / security in addition to existing charge / mortgage / pledge / hypothecation / security, in such form and manner and with such ranking and at such time and on such terms as the Board may determine on all or any of the assets of the Company whether immovable or movable, tangible or intangible both present and future and / or the whole or any part of the undertaking(s) of the Company, as the case may be in favour of any lenders or trustees to secure the amount borrowed by the Company from time to time for the due payment of the principal together with interest, charges, costs, expenses and all other monies payable by the Company in respect of such borrowings, for which the charge is to be created, shall not, at any time exceed Rs. 5,000 Crores.MoreLess
    1 for0 against

Mutual fund votes, meeting of 11 Jan 2025, 17 fund houses

  • To Re-appoint Dr. Emmanuel Rupert (DIN: 07010883) as Managing Director and Group Chief Executive Officer of the Company for a period of three years effective February 11, 2025 to February 10, 2028
    17 for0 against

Mutual fund votes, meeting of 30 Aug 2024, 18 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the audited nstandalone financial statements of the Company for nthe financial year ended March 31, 2024, together nwith the reports of the Board of Directors and the nAuditors thereon.MoreLess
    14 for0 against
  • To receive, consider and adopt the audited nconsolidated financial statements of the Company nfor the financial year ended March 31, 2024, together nwith the report of the Auditors thereon.
    14 for0 against
  • To declare dividend of Rs. 4.00 per Equity Share for nthe financial year ended March 31, 2024
    17 for0 against
  • To appoint a Director in place of Mr. Viren Prasad nShetty (DIN: 02144586), who retires by rotation and nbeing eligible, offers himself for re-appointment.
    17 for0 against
  • To ratify the remuneration payable to the Cost nAuditors for the Financial Year 2024-25
    5 for0 against
  • To appoint Ms. Nivruti Rai (DIN: 01353079) as an nIndependent Director of the Company
    17 for0 against
  • To appoint Dr. Anesh Shetty (DIN: 06923555) as a nNon-Executive Non-Independent Director of the nCompany.
    17 for0 against
  • To approve revision in remuneration of Dr. Devi nPrasad Shetty (DIN: 00252187) as Whole-time nDirector of the Company
    Against Bandhan Mutual Fund, Groww Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Combined position of Executive Director and Chairman of the Company. No other concerns.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    13 for4 against
  • To approve revision in remuneration of Mr. Viren nPrasad Shetty (DIN:02144586) as Whole-time nDirector, designated as Executive Vice Chairman of nthe Company
    17 for0 against
  • To approve revision in remuneration of Dr. Emmanuel nRupert (DIN: 07010883), as Managing Director and nGroup CEO of the Company
    17 for0 against
  • To approve revision in professional fee payable to nDr. Varun Shetty as a Consultant Surgeon, an office nor place of profit under the Companies Act, 2013.
    Against Aditya Birla Sun Life Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Sundaram Mutual Fund
    • Aditya Birla Sun Life Mutual Fund, Sundaram Mutual FundDr. Varun Shetty is son of Dr. Devi Prasad Shetty, promoter Chairperson. His remuneration was revised to Rs. 26.0 mn in FY22 AGM. His maximum proposed revision effective 1 April 2024 is Rs. 36.0 mn. We raise concern that Dr. Varun Shetty’s proposed remuneration will increase by 38.5% over FY22 limits approved by shareholders at the FY22 AGM. Further, the proposed remuneration of Rs. 36.0 mn is higher than the FY24 remuneration of Executive Director Viren Shetty – Rs. 33.2 mn: there is neither clarity on the rationale nor his role and responsibilities. The company must also benchmark the proposed remuneration with that paid to other doctors with similar experience in the company. We do not support the resolution.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual FundNon-compliance with Companies Act, 2013: Prior approval not sought.
    • Kotak Mahindra Mutual FundGiven that Dr. Varun Shetty is Consultant Surgeons and hold a office of profit, their appointment comes under the Rule 15 (3)(b) of Chapter XII of the Companies Rules, 2014. The Company is seeking shareholders approval almost after 5 months of the commencement of their revision of remuneration. Therefore, in accordance with the above-mentioned rule, the appointment is non-compliant as the Company has already revised the salary; i.e., before the shareholders approval being sought. Hence voting against.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    8 for9 against
  • To approve the professional fee payable to Dr. Vivek nShetty as a Consultant Surgeon, an office or place nof profit under the Companies Act, 2013.
    Against Aditya Birla Sun Life Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Sundaram Mutual Fund
    • Aditya Birla Sun Life Mutual Fund, Sundaram Mutual FundDr. Vivek Shetty’s is the son in law of Dr. Devi Prasad Shetty, promoter Chairperson. He has been working as a Consultant Surgeon in the department of Head and Neck Oncology at Mazumdar Shaw Cancer Center. In FY24, he was paid Rs. 9.8 mn. The company seeks to retain his current remuneration limits and hence, his maximum proposed remuneration effective 1 April 2024 is Rs. 15.0 mn. Dr. Vivek Shetty’s role and responsibilities for the proposed remuneration are unclear. The company must benchmark the proposed remuneration with that paid to other doctors with similar experience in the company. We do not support the resolution.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual FundNon-compliance with Companies Act, 2013: Prior approval not sought.
    • Kotak Mahindra Mutual FundGiven that Dr. Vivek Shetty is a Consultant Surgeons and hold a office of profit, their appointment comes under the Rule 15 (3)(b) of Chapter XII of the Companies Rules, 2014. The Company is seeking shareholders approval almost after 5 months of the commencement of their revision of remuneration. Therefore, in accordance with the above-mentioned rule, the appointment is non-compliant as the Company has already revised the salary; i.e., before the shareholders approval being sought. Hence voting against.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    8 for9 against
  • To approve issue of Debt Securities on Private nPlacement Basis
    17 for0 against
  • Increase in borrowing powers of Board of Directors nunder Section 180(1)(c) of the Companies Act, 2013
    1 for0 against
  • Increase in provision for security in connection nwith the borrowings not exceeding Rs.3,000 Crores nunder Section 180(1)(a) of the Companies Act, 2013
    1 for0 against
24 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    Against Taurus Mutual Fund
    • Taurus Mutual FundDr. Vivek Shetty’s is the son in law of Dr. Devi Prasad Shetty, promoter Chairperson. He has been working as a Consultant Surgeon in the department of Head and Neck Oncology at Mazumdar Shaw Cancer Center. In FY24, he was paid Rs. 9.8 mn. The company seeks to retain his current remuneration limits and hence, his maximum proposed remuneration effective 1 April 2024 is Rs. 15.0 mn. Dr. Vivek Shetty’s role and responsibilities for the proposed remuneration are unclear. The company must benchmark the proposed remuneration with that paid to other doctors with similar experience in the company. We do not support the resolution.
    0 for1 against
  • Item 8, as a fund house numbered it
    1 for0 against
  • Item 9, as a fund house numbered it
    1 for0 against
  • Item 10, as a fund house numbered it
    1 for0 against
  • Item 11, as a fund house numbered it
    1 for0 against
  • Item 12, as a fund house numbered it
    1 for0 against
  • Item 13, as a fund house numbered it
    1 for0 against
  • Item 14, as a fund house numbered it
    1 for0 against
  • Item 15, as a fund house numbered it
    Against Taurus Mutual Fund
    • Taurus Mutual FundDr. Varun Shetty is son of Dr. Devi Prasad Shetty, promoter Chairperson. His remuneration was revised to Rs. 26.0 mn in FY22 AGM. His maximum proposed revision effective 1 April 2024 is Rs. 36.0 mn. We raise concern that Dr. Varun Shetty’s proposed remuneration will increase by 38.5% over FY22 limits approved by shareholders at the FY22 AGM. Further, the proposed remuneration of Rs. 36.0 mn is higher than the FY24 remuneration of Executive Director Viren Shetty – Rs. 33.2 mn: there is neither clarity on the rationale nor his role and responsibilities. The company must also benchmark the proposed remuneration with that paid to other doctors with similar experience in the company. We do not support the resolution.
    0 for1 against
  • 14) Approve increase in borrowing limits to Rs.30.0 bn from Rs.15.0 bn.
    1 for0 against
  • 15) Approve increase in limit for creation of charge on the assets to Rs.30.0 bn from Rs.15.0 bn.
    1 for0 against
  • Adoption of consolidated financial statements for the year ended 31 March 2024
    3 for0 against
  • Adoption of standalone financial statements for the year ended 31 March 2024
    3 for0 against
  • Approve increase in borrowing limits to Rs.30.0 bn from Rs.15.0 bn
    3 for0 against
  • Approve increase in limit for creation of charge on the assets to Rs.30.0 bn from Rs.15.0 bn
    3 for0 against
  • Ratification of remuneration Rs. 4,00,000/- per annum plus applicable taxes and out of pocket expenses payable to M/s. PSV and Associates, Cost Accountants, Bengaluru (Firm Registration Number: 000304) who has been appointed by the Board of Directors of the Company as Cost Auditors to conduct the audit of cost records for the financial year ending March 31, 2025.MoreLess
    12 for0 against
  • To borrow any sum or sums of moneys from time to time, for the purpose of business of the Company in Indian rupee currency and / or foreign currency from, including but not limited to, any one or more banks, financial institutions, persons, firms, companies and bodies corporates, notwithstanding that the money or moneys to be borrowed, together with the moneys already borrowed by the Company (apart from temporary loans obtained from the Company’s Bankers in the ordinary course of business), may exceed aggregate of its paid-up share capital and free reserves, provided however, the total amount so borrowed shall not exceed Rs 3,000 crores.MoreLess
    12 for0 against
  • To pledge mortgage hypothecate and/ or to create charge / security in addition to existing charge / mortgage / pledge / hypothecation / security, in such form and manner and with such ranking and at such time and on such terms as the Board may determine on all or any of the assets of the company whether immovable or movable, tangible or intangible both present and future and / or the whole or any part of the undertaking(s) of the Company, as the case may be in favour of any lenders or trustees to secure the amount borrowed by the Company and / or its subsidiaries, associates and joint ventures from time to time for the due payment of the principal together with interest, charges, costs, expenses and all other monies payable by the Company or the subsidiaries, associates and joint ventures in respect of such borrowings.MoreLess
    12 for0 against

Mutual fund votes, meeting of 4 Aug 2023, 12 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the audited financial statements of the Company including the audited consolidated financial statements for the financial year ended 31st March 2023, together with the reports of the Board of Directors and the Auditors thereonMoreLess
    11 for0 against
  • To declare dividend of Rs. 2.50 per Equity Share for the financial year ended 31st March 2023
    11 for0 against
  • To appoint a director in place of Dr. Kiran Mazumdar Shaw (DIN: 00347229), who retires by rotation and being eligible, offers herself for re-appointment
    11 for0 against
  • To ratify remuneration payable to the Cost Auditors for the Financial Year 2023-24
    11 for0 against
  • To approve revision in remuneration of Dr. Devi Prasad Shetty (DIN: 00252187) as Whole- time Director of the Company till the end of his current tenure, i.e. upto 28th August 2023
    Against JM Financial Mutual Fund, Motilal Oswal Mutual Fund
    • JM Financial Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Combined position of Executive Director and Chairman of the Company.
    9 for2 against
  • To approve revision in remuneration of Mr. Viren Prasad Shetty (DIN:02144586) as Whole-time Director, designated as Executive Vice Chairman of the Company till the end of his current tenure, i.e. upto 28th August 2023MoreLess
    11 for0 against
  • To approve revision in remuneration of Dr. Emmanuel Rupert (DIN: 07010883), as Managing Director and Group CEO of the Company
    Against HDFC Mutual Fund
    • HDFC Mutual FundThe proposed remuneration is high considering the size and complexity of the business
    10 for1 against
  • To approve re-appointment of Dr. Devi Prasad Shetty (DIN:00252187) as Whole-time Director of the Company for a term of five years effective from 29th August 2023
    Against JM Financial Mutual Fund, Motilal Oswal Mutual Fund
    • JM Financial Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Combined position of Executive Director and Chairman of the Company.
    9 for2 against
  • To approve re-appointment of Mr. Viren Prasad Shetty (DIN:02144586), as Whole-time Director (designated as Executive Vice Chairman) of the Company for a term of five years effective from 29th August 2023MoreLess
    11 for0 against
  • To approve issue of Debt Securities on Private Placement Basis
    11 for0 against
10 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    Against Taurus Mutual Fund
    • Taurus Mutual FundDr. Emmanuel Rupert was paid a remuneration of 65.9 mn in FY23. His stated remuneration for FY23 was Rs. 141.1 mn which was on account of perquisite value of stock options exercised. Based on a market benchmarking study, the company has recommended a 15% increase in existing remuneration limits to Rs. 75.7 mn from FY23 onwards. While we recognize that his FY24 fixed remuneration will be in line with peers and the performance of the company, he is also entitled to stock options at face value of Rs. 10.0 each. The company has not disclosed any details regarding any grants he may receive during his current tenure. In addition to his revised fixed remuneration, any future grants of stock options is likely to increase his remuneration to levels above peers. Further, the company has not disclosed any performance metrics that will determine the performance/ variable pay. We note that the proposed remuneration shall be paid to him notwithstanding the regulatory limits.
    0 for1 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against
  • Item 8, as a fund house numbered it
    1 for0 against
  • Item 9, as a fund house numbered it
    1 for0 against
  • Item 10, as a fund house numbered it
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Fines

Reported in the filing for the quarter to Sep 2026.

  • Fine or penaltyJoint Commissioner of Commercial Taxes (Appeals-8), Bengaluru.Since 1 Sep 2026

    PENALTY OF RS. 261388 IMPOSED BY ORDER UNDER SECTION 107(11) OF THE KARNATAKA GOODS AND SERVICES TAX ACT 2017 AND CENTRAL GOODS SERVICES TAX ACT 2017

    The penalty was imposed by the GST Department on the grounds that the Company had allegedly overstated Input Tax Credit (ITC) claimed. The Company does not concur with the findings and has decided to challenge the order before the GST Appellate Tribunal (GSTAT). The process of filing the appeal is currently underway.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Jun 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
Yes
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.